How to Choose the Right CDMO
April 02, 2026
Your science is ready.
The mechanism is well-characterized, the preclinical data is compelling, and the clinical development...
Read more →At Advanced Therapies Week 2026, our Chief Technology Officer, Gregg Nyberg, joined a panel of industry leaders to discuss how advanced therapy developers are navigating the path...
Read More →April 02, 2026
Your science is ready.
The mechanism is well-characterized, the preclinical data is compelling, and the clinical development...
Read more →February 26, 2026
Extracellular vesicles have been a subject of scientific fascination for decades. For most of that time, they were studied...
Read more →January 22, 2026
In today’s rapidly evolving biotech landscape, the efficient flow and integration of data across various systems and functions...
Read more →December 15, 2025
Cell and gene therapies (CGTs) have advanced from conceptual promise to clinical reality, with dozens of approved products and...
Read more →November 12, 2025
CAR-T therapies have redefined cancer treatment, moving from bold hypothesis to frontline standard in less than a decade. With...
Read more →